Switch to:
More From Other Websites
Genmab A/S Summons Annual General Meeting Mar 03 2015
Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective Mar 02 2015
Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology Feb 19 2015
GENCOR INDUSTRIES INC Financials Feb 13 2015
10-Q for Gencor Industries, Inc. Feb 08 2015
Gencor Releases First Quarter Fiscal 2015 Results Feb 06 2015
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 06 2015
GENCOR INDUSTRIES INC Files SEC form 10-Q, Quarterly Report Feb 06 2015
Major Shareholder Announcement Feb 04 2015
Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple... Feb 04 2015
Fourth Quarter and Full Year 2014 Net Sales Figures for Arzerra (ofatumumab) Feb 04 2015
Genmab to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
Report Pursuant to Section 28a of the Danish Securities Trading Act Dec 15 2014
Grant of Restricted Stock Units to Board Members and Management and Grant of Warrants to Management... Dec 15 2014
Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen Dec 12 2014
10-K for Gencor Industries, Inc. Dec 11 2014
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 09 2014
GENCOR INDUSTRIES INC Files SEC form 10-K, Annual Report Dec 09 2014
Gencor Releases Fiscal Year and Fourth Quarter 2014 Results Dec 09 2014
Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas Dec 04 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK